2022
DOI: 10.1007/s13577-022-00671-y
|View full text |Cite
|
Sign up to set email alerts
|

Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li–Fraumeni syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…The limitations of commercial cell lines include typically poor correlations between cell lines and diseases, limited availability of cell lines representing STS subtypes, and reduced efficiency for in vivo studies compared with other cancers. Thus, while many STS cell lines have been established (14)(15)(16)(17), only a few are tumorigenic in vivo after transplantation.…”
Section: Introductionmentioning
confidence: 99%
“…The limitations of commercial cell lines include typically poor correlations between cell lines and diseases, limited availability of cell lines representing STS subtypes, and reduced efficiency for in vivo studies compared with other cancers. Thus, while many STS cell lines have been established (14)(15)(16)(17), only a few are tumorigenic in vivo after transplantation.…”
Section: Introductionmentioning
confidence: 99%